The company's vertical integration from being a pharmaceuticals manufacturer to growing own consumer brands finds investor backing.
Fredun Pharma raising ₹153 crores
The company's vertical integration from being a pharmaceuticals manufacturer to growing own consumer brands finds investor backing.